Quaker Chemical Corporation (KWR)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NYSE
Market Cap: $2.67B
Last updated: Nov 17, 2026 at 11:06 AM ET
Quaker Chemical Corporation (KWR) Stock Forecast
Analysts expect Quaker Chemical (KWR) to earn $7.99 per share in the fiscal year ending Dec 31, 2026, on revenue of $2.05B. Of 7 analysts, 7 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 1.71, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 2 | 28.6% |
| Buy | 5 | 71.4% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 7
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 18.4% and revenue estimates rise 4.9%.
- Fiscal year ending Dec 31, 2026
- $7.99
- EPS consensus, revenue $2.05B
- Fiscal year ending Dec 31, 2027
- $9.46
- EPS consensus, revenue $2.15B
- Next report
- Feb 22, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $7.99 | $7.67 to $8.35 | 7 | $2.05B | $2.01B to $2.07B | 7 |
| Dec 31, 2027 | $9.46 | $8.90 to $10.35 | 7 | $2.15B | $2.12B to $2.18B | 7 |
Quarterly Estimates
The EPS consensus rises from $1.84 for the quarter ending Dec 31, 2026 to $1.88 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.84 | $1.69 to $2.25 | 8 | $510.62M | $472.36M to $541.17M | 7 |
| Mar 31, 2027 | $1.88 | $1.76 to $2.04 | 3 | $515.07M | $504.50M to $523.70M | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 5 upward and 4 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 0 |
| Fiscal year ending Dec 31, 2027 | 2 | 3 |
| Quarter ending Mar 31, 2027 | 1 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 6.1% from $7.53.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $7.99 | $7.87 | $7.87 | $7.86 | $7.53 | +6.1% |
| Fiscal year ending Dec 31, 2027 | $9.46 | $9.56 | $9.53 | $9.51 | $9.25 | +2.3% |
| Quarter ending Mar 31, 2027 | $1.88 | $2.01 | $1.99 | $1.99 | $1.96 | -4.1% |
Frequently Asked Questions About KWR
What is the KWR stock forecast?
Consensus analyst estimates put Quaker Chemical's EPS at $7.99 for the fiscal year ending Dec 31, 2026, on revenue of $2.05B. The consensus rating from 7 analysts is Buy.
How do analysts rate KWR stock?
Of 7 analysts covering Quaker Chemical, 2 rate it Strong Buy, 5 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from KWR next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $7.99, with estimates from $7.67 to $8.35 from 7 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $9.46, with estimates from $8.90 to $10.35 from 7 analysts.
What revenue do analysts expect from Quaker Chemical next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.05B, with estimates from $2.01B to $2.07B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $2.15B, with estimates from $2.12B to $2.18B.
How many analysts cover KWR?
7 analysts rate Quaker Chemical stock, and 7 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
KWR pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts